Watson Targets Teva's Patent For LoSeasonique

Law360, New York (February 26, 2010, 6:08 PM EST) -- Watson Laboratories Inc. has filed a declaratory judgment suit against Teva Women’s Health Inc., seeking a ruling that its bid to make a generic version of oral contraceptive Seasonique does not infringe a separate patent covering a lower dosage of the drug.

The generics maker filed its complaint Thursday in the U.S. District Court for the District of Nevada, disputing the validity of a “nearly identical” patent assigned to the Teva unit, formerly known as Duramed Pharmaceuticals Inc.

Watson brought the suit to “avoid legal uncertainty...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.